greeksoup/ stock research
Stock research / United States / ANGO / Documents

Angiodynamics Inc. documents

Angiodynamics (ANGO) annual report: the 10-K filed 14 July 2026 for the year ended 31 May 2026. Proxy statement (DEF 14A) filed 8 October 2026; latest 10-Q filed 8 October 2026 for the quarter ended 31 August 2026. Each links to the document on EDGAR, with 4 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
8 October 2026Results press release, exhibit 99 to the 8-K filed 8 October 2026The releaseEDGAR folder
14 July 2026Results press release, exhibit 99 to the 8-K filed 14 July 2026The releaseEDGAR folder
2 April 2026Results press release, exhibit 99 to the 8-K filed 2 April 2026The releaseEDGAR folder
6 January 2026Results press release, exhibit 99 to the 8-K filed 6 January 2026The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
29 September 202610-K/A, period ended 31 May 2026The documentEDGAR folder
29 September 202610-K/A, period ended 31 May 2026The documentEDGAR folder
14 July 202610-K, period ended 31 May 2026The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
8 October 202610-Q, period ended 31 August 2026The documentEDGAR folder
2 April 202610-Q, period ended 28 February 2026The documentEDGAR folder
6 January 202610-Q, period ended 30 November 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
8 October 2026DEF 14A, period ended 17 November 2026The documentEDGAR folder